Indivior Pharmaceuticals, Inc. INDV Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Profitability | ||||
| Gross margin | 80.2%-0.4pp | 80.6%-3.5pp | 84.1%+0.8pp | |
| Operating margin | 21.1%+17.9pp | 3.2%+17.1pp | -13.9%-5.4pp | |
| Net margin | 16.9%+16.3pp | 0.6%+12.1pp | -11.5%-6.9pp | |
| EBITDA margin | 21.9%+17.4pp | 4.5%+17.1pp | -12.5%-5.8pp | |
| Free cash flow margin | -7.5%— | —— | -28.2%-27.2pp | |
| Returns | ||||
| Return on assets | 16.6%+16.2pp | 0.5%— | —— | |
| Efficiency | ||||
| Asset turnover | 1×+0.2× | 0.8×— | —— | |
| Inventory turnover | 41×+37.6× | 3.4×+0.8× | 2.6×— | |
| Liquidity | ||||
| Current ratio | 0.7×-0.2× | 0.9×-0.1× | 1×— | |
| Quick ratio | 0.7×-0.2× | 0.9×0.0× | 0.9×— | |
| Cash ratio | 0.2×-0.1× | 0.3×+0.1× | 0.2×— | |
| Leverage | ||||
| Debt-to-assets | 0.3×0.0× | 0.3×+0.1× | 0.2×— | |
| Net debt / EBITDA | 0.6×-0.5× | 1×— | —— | |
| Interest coverage | 5.8×+4.9× | 0.9×+5.2× | -4.3×-1.5× | |
| Per Share | ||||
| Book value per share | -$0.77+69.8% | -$2.53-88.7% | -$1.34-1,145% | |
| Valuation | ||||
| Market capitalization | $4.49B+189% | $1.55B-24.3% | $2.05B— | |
| Enterprise value | $4.64B+188% | $1.61B-20.2% | $2.02B— | |
| Price / earnings | 21.5×-200× | 221.9×— | —— | |
| Price / sales | 3.6×+2.3× | 1.3×-0.6× | 1.9×— | |
| EV / EBITDA | 17.1×-12.7× | 29.8×— | —— | |
| EV / sales | 3.7×+2.4× | 1.4×-0.5× | 1.8×— | |
| Free cash flow yield | -2.1%— | —— | -15%— | |
| Earnings yield | 4.7%+4.2pp | 0.5%+6.6pp | -6.1%— | |
| PEG ratio | 0×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Indivior Pharmaceuticals, Inc. 's profit margins?
- Indivior Pharmaceuticals, Inc. (INDV) runs a 81.3% gross margin and a 25.8% operating margin, with a 19.4% net margin.
- Where do Indivior Pharmaceuticals, Inc. 's ratios come from?
- Every ratio is computed from Indivior Pharmaceuticals, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.